## Variants and diseases

### Relational list using [ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/)

|Disease|Disease description|Gene|Variantsï¼ˆHGVS)|
|-------|-------------------|----|--------|
|Hemochromatosis|A disorder that causes the body to absorb too much iron from the diet|HJV|NM_213653.4:c.187C>T|
|Thalassemia|	A group of blood disorders that affect hemoglobin production	|	ATRX	|	NM_000489.6:c.6253C>T	|
|Haemophilia|	A genetic disorder that impairs blood clotting 	|	F9	|	A genetic disorder that impairs blood clotting 	|
|Cystic Fibrosis|	A hereditary disorder affecting the lungs and digestive system	|	CFTR	|	NM_000492.4:c.3623del 	|
|Tay sachs disease|	A rare genetic disorder that affects the nervous system 	|	HEXA	|	NM_000520.6:c.1385A>T	|
|Fragile X syndrome|	A genetic condition causing intellectual and developmental delays	|	FMR1	|	NM_000302.4(PLOD1):c.1533C>G	|
|Huntington's disease|	A neurodegenerative disorder leading to motor and cognitive decline	|	HTT	|	NM_001388492.1(HTT):c.54GCA[40]	|



### Relational list using [ClinGen](https://clinicalgenome.org/)

|Gene|Gene name|Chromosomal location|Gene product|Disease|Disease description|
|----|---------|--------------------|------------|-------|-------------------|
|CFTR|CF transmembrane conductance regulator|7q31.2|epithelial ion channel, transport of chloride ions across the cell membrane|Cystic fibrosis|a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity|		 |
|CYBB|	    cytochrome b-245 beta chain	    |	Xp21.1-p11.4	| 	Part of the phagocyte NADPH oxidase (NOX2) enzyme complex  	|	granulomatous disease, chronic, X-linked	|	A genetic disorder characterized by recurrent bacterial and fungal infections due to impaired phagocytic function	 |
|HJV|	hemojuvelin BMP co-receptor	    |	1q21.1	|	Acts as a bone morphogenetic protein (BMP) coreceptor	|	 	hemochromatosis type 2A	|	A disorder that causes the body to absorb too much iron from the diet|
|CDKN2A|	    cyclin dependent kinase inhibitor 2A	|	9p21.3	|	Regulates cell cycle progression and tumor suppression	|	melanoma-pancreatic cancer syndrome	|	Predisposes individuals to various cancers, including melanoma	 |
|KRAS|		    KRAS proto-oncogene, GTPase    |	    12p12.1	|	Ras proteins bind GDP/GTP and possess intrinsic GTPase activity 	|	Noonan syndrome, cardiofaciocutaneous syndrome	|		Mutations can lead to the development of several types of cancer |
|TP53|	     tumor protein p53   	|	    17p13.1	|	Regulates cell cycle and acts as a tumor suppressor	|		Li-Fraumeni syndrome 1,	familial ovarian cancer	|	Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type.  |
|	FMR1 |	    fragile X messenger ribonucleoprotein 1	    |	    Xq27.3	|	RNA-binding protein involved in synaptic function	|Fragile X syndrome|a genetic disorder characterized by mild-to-moderate intellectual disability|


